Atossa Therapeutics
ATOS
#10745
Rank
NZ$36.45 M
Marketcap
NZ$3.65
Share price
2.55%
Change (1 day)
162.70%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -NZ$65.51 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$63.2 Million a decrease over its 2024 earnings that were of -NZ$46.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$65.51 Million3.65%
2025 -NZ$63.2 Million36.33%
2024 -NZ$46.36 Million-15.25%
2023 -NZ$54.7 Million11.62%
2022 -NZ$49 Million30.84%
2021 -NZ$37.46 Million15.58%
2020 -NZ$32.41 Million3.41%
2019 -NZ$31.34 Million51.16%
2018 -NZ$20.73 Million40.41%
2017 -NZ$14.77 Million27.54%
2016 -NZ$11.58 Million-47.49%
2015 -NZ$22.05 Million-17.25%
2014 -NZ$26.65 Million35.91%
2013 -NZ$19.61 Million112.3%
2012 -NZ$9.24 Million46.53%
2011 -NZ$6.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.02 B-49,745.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$2.71 B-4,056.62%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$2.64 B-3,958.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$75.75 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-NZ$59.86 Million-12.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-NZ$14.26 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA